索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]舒宏运,李健洪,李金花,等.PCSK9通过细胞程序性死亡参与主动脉瘤和夹层的发生和进展[J].国际心血管病杂志,2025,01:28-31.
点击复制

PCSK9通过细胞程序性死亡参与主动脉瘤和夹层的发生和进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2025年01期
页码:
28-31
栏目:
综述
出版日期:
2025-01-25

文章信息/Info

Title:
-
作者:
舒宏运; 李健洪; 李金花; 吕自明; 李巧汶
511518 广州医科大学附属清远医院（清远市人民医院）心血管内科（舒宏运，李健洪，李金花，吕自明）；510550 广州市老年医院心血管内科（李巧汶）
Author(s):
-
关键词:
前蛋白转化酶枯草溶菌素9; 主动脉瘤; 主动脉夹层; 细胞程序性死亡
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2025.01.008
文献标识码:
-
摘要:
前蛋白转化酶枯草溶菌素9（PCSK9）属于前蛋白转化酶家族，不仅能影响脂质代谢，还能通过细胞程序性死亡（PCD）参与主动脉瘤和夹层（AAD）发病。该文介绍PCSK9通过介导细胞凋亡、自噬、焦亡和铁死亡等PCD过程参与AAD的发生和进展。
Abstract:
-

参考文献/References

[1] Quintana RA, Taylor WR. Introduction to the compendium on aortic aneurysms[J]. Circ Res, 2019, 124(4):470-471.
[2] Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes[J]. Nat Rev Cardiol, 2021, 18(5):331-348.
[3] Iida Y, Tanaka H, Sano H, et al. Ectopic expression of PCSK9 by smooth muscle cells contributes to aortic dissection[J]. Ann Vasc Surg, 2018, 48:195-203.
[4] Hummelgaard S, Vilstrup JP, Gustafsen C, et al. Targeting PCSK9 to tackle cardiovascular disease[J]. Pharmacol Ther, 2023, 249:108480.
[5] Tsujimoto Y. Multiple ways to die: non-apoptotic forms of cell death[J]. Acta Oncol, 2012, 51(3):293-300.
[6] Tavori H, Giunzioni I, Predazzi IM, et al. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms[J]. Cardiovasc Res, 2016, 110(2):268-278.
[7] Liu SJ, Wu JZ, Stolarz A, et al. PCSK9 attenuates efferocytosis in endothelial cells and promotes vascular aging[J]. Theranostics, 2023, 13(9):2914-2929.
[8] Guo YN, Yan BJ, Gui Y, et al. Physiology and role of PCSK9 in vascular disease: potential impact of localized PCSK9 in vascular wall[J]. J Cell Physiol, 2021, 236(4):2333-2351.
[9] 夏佳春, 侯磊. PCSK9在动脉粥样硬化性心血管疾病炎性反应中的作用[J]. 国际心血管病杂志, 2023, 50(1):5-8.
[10] Chen Y, He Y, Wei X, et al. Targeting regulated cell death in aortic aneurysm and dissection therapy[J]. Pharmacol Res, 2022, 176:106048.
[11] McCrann DJ, Nguyen HG, Jones MR, et al. Vascular smooth muscle cell polyploidy: an adaptive or maladaptive response?[J]. J Cell Physiol, 2008, 215(3):588-592.
[12] Guo YN, Tang ZH, Yan BJ, et al. PCSK9 (proprotein convertase subtilisin/kexin type 9) triggers vascular smooth muscle cell senescence and apoptosis: implication of its direct role in degenerative vascular disease[J]. Arterioscler Thromb Vasc Biol, 2022, 42(1):67-86.
[13] Tanaka H, Inuzuka K, Iida Y, et al. Proprotein convertase subtilisin/kexin type 9 is associated with degenerating adipocytes in abdominal aortic aneurysm[J]. J Oleo Sci, 2018, 67(10):1355-1360.
[14] Ding ZF, Liu SJ, Wang XW, et al. Cross-talk between PCSK9 and damaged mtDNA in vascular smooth muscle cells: role in apoptosis[J]. Antioxid Redox Signal, 2016, 25(18):997-1008.
[15] Li J, Liang X, Wang YY, et al. Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis[J]. Mol Med Rep, 2017, 16(2):1817-1825.
[16] Green DR. Caspase activation and inhibition[J]. Cold Spring Harb Perspect Biol, 2022, 14(8):a041020.
[17] Sundararaman SS, D?ring Y, van der Vorst EPC. PCSK9: a multi-faceted protein that is involved in cardiovascular biology[J]. Biomedicines, 2021, 9(7):793.
[18] Wu CY, Tang ZH, Jiang L, et al. PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway[J]. Mol Cell Biochem, 2012, 359(1-2):347-358.
[19] Shen WL, Tian C, Chen H, et al. Oxidative stress mediates chemerin-induced autophagy in endothelial cells[J]. Free Radic Biol Med, 2013, 55:73-82.
[20] Ren HG, Dai RC, Nik Nabil WN, et al. Unveiling the dual role of autophagy in vascular remodelling and its related diseases[J]. Biomed Pharmacother, 2023, 168:115643.
[21] 袁得强, 林浩, 朱国旗, 等. 自噬在动脉粥样硬化中的研究进展[J]. 同济大学学报（医学版）, 2022, 43(1):138-144.
[22] Li GH, Wang XP, Yang HY, et al. α-Linolenic acid but not linolenic acid protects against hypertension: critical role of SIRT3 and autophagic flux[J]. Cell Death Dis, 2020, 11(2):83.
[23] D'Onofrio N, Prattichizzo F, Marfella R, et al. SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells[J]. Theranostics, 2023, 13(2):531-542.
[24] Marfella R, Prattichizzo F, Sardu C, et al. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque[J]. Atherosclerosis, 2023, 378:117180.
[25] Fang ZM, Feng X, Chen Y, et al. Targeting autophagy in aortic aneurysm and dissection[J]. Biomed Pharmacother, 2022, 153:113547.
[26] Lu HC, Sun JJ, Liang WY, et al. Cyclodextrin prevents abdominal aortic aneurysm via activation of vascular smooth muscle cell transcription factor EB[J]. Circulation, 2020, 142(5):483-498.
[27] Chen C, Gao LL, Ge HW, et al. A neural network model was constructed by screening the potential biomarkers of aortic dissection based on genes associated with pyroptosis[J]. Aging (Albany NY), 2023, 15(21):12388-12399.
[28] Ruscica M, Ferri N, Macchi C, et al. Lipid lowering drugs and inflammatory changes: an impact on cardiovascular outcomes?[J]. Ann Med, 2018, 50(6):461-484.
[29] Huang LX, Li YJ, Cheng Z, et al. PCSK9 promotes endothelial dysfunction during sepsis via the TLR4/MyD88/NF-κB and NLRP3 pathways[J]. Inflammation, 2023, 46(1):115-128.
[30] Zeng JF, Tao J, Xi LZ, et al. PCSK9 mediates the oxidative low-density lipoprotein-induced pyroptosis of vascular endothelial cells via the UQCRC1/ROS pathway[J]. Int J Mol Med, 2021, 47(4):53.
[31] Wang YN, Fang D, Yang QZ, et al. Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis[J]. Front Immunol, 2023, 14:1126823.
[32] Martino E, D'Onofrio N, Balestrieri A, et al. MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4[J]. Cell Mol Biol Lett, 2023, 28(1):66.
[33] Wang K, Chen XZ, Wang YH, et al. Emerging roles of ferroptosis in cardiovascular diseases[J]. Cell Death Discov, 2022, 8(1):394.
[34] Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5):1060-1072.
[35] Sarad K, Stefańska M, Kraszewska I, et al. Single-cell transcriptomics reveals subtype-specific molecular profiles in Nrf2-deficient macrophages from murine atherosclerotic aortas[J]. Front Immunol, 2023, 14:1249379.
[36] Ding ZF, Liu SJ, Wang XW, et al. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta[J]. Antioxid Redox Signal, 2015, 22(9):760-771.
[37] Zhuang JL, Zhu H, Cheng ZQ, et al. PCSK9, a novel immune and ferroptosis related gene in abdominal aortic aneurysm neck[J]. Sci Rep, 2023, 13(1):6054.

备注/Memo

备注/Memo:
通信作者：李巧汶，E-mail：Stevenxzf@sina.com
更新日期/Last Update: 2025-02-10